ArticleBMC complementary medicine and therapies2025
Multitarget inhibitory effects of lemongrass essential oil on Porphyromonas gingivalis: synergistic regulation of heme utilization, biofilm formation, and the metabolic pathway of ferroptosis.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSevere periodontitis has impacted upwards of 1 billion people worldwide, posing a public health challenge. Porphyromonas gingivalis (P. gingivalis) is a keystone pathogen implicated in periodontal dysbiosis and disease progression. Lemongrass essential oil (LEO), extracted from Cymbopogon citratus (DC.) Stapf, has shown clinical benefits in periodontitis management, yet its mechanisms remain poorly understood.
methodsAntibacterial and bactericidal activities of LEO against P. gingivalis were evaluated, along with its effects on heme uptake and storage, early biofilm-related phenotypes, mature biofilm development, and transcriptional regulation of virulence-associated genes. Docking simulations were performed to predict interactions between metabolites identified via GC-MS and virulence-related proteins. LEO's effects on oxidative stress, inflammatory cytokine secretion, and ferroptosis-related gene expression were also evaluated in LPS-induced RAW 264.7 macrophages.
resultsThe antibacterial efficacy of LEO against P. gingivalis was evidenced by a 51.10 ± 2.17 mm inhibition zone, along with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of 34.06 and 68.13 µg/mL, respectively. Growth curve analysis showed sustained suppression over 30 h. At 1/4 - 1/2 MIC, LEO inhibited P. gingivalis hemagglutination, hemolysis (p < 0.05), and heme accumulation. Moreover, biofilm formation was significantly reduced by over 85% at 1/2 MIC though suppression of autoaggregation and hydrophobicity (p < 0.05). Molecular docking analysis predicted that α-citral (46.41%) and neral (31.58%), the major metabolites of LEO, may act as potential bioactive metabolites. In addition, LEO significantly reduced the levels of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6), notably decreasing TNF-α secretion to 0.82× and 0.66× (MIC and MBC, respectively) relative to the LPS group (p < 0.05). It also alleviated oxidative stress through slc7a11 upregulation and subsequent glutathione synthesis, leading to restoration of the GSH/GSSG ratio and a reduction in ROS and MDA levels (p < 0.05). Moreover, LEO downregulated Tfrc expression and decreased Fe²⁺ accumulation (p < 0.05), suggesting its potential role in restoring iron homeostasis and suppressing ferroptosis-associated markers, such as Ptgs2. These effects highlight the multifunctional regulatory capacity of LEO during P. gingivalis-LPS-induced inflammatory stress.
conclusionLEO demonstrated multitarget inhibitory effects by attenuating P. gingivalis virulence and regulating macrophage oxidative and iron homeostasis. These findings support its potential as a natural adjunctive or preventive agent in periodontitis therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.